Literature DB >> 33495142

Repeat transcatheter aortic valve replacement and implications for transcatheter heart valve performance: insights from bench testing.

Janarthanan Sathananthan1, Rob Fraser, Uri Landes, Courtney Rich, Stephanie L Sellers, Jonathon Leipsic, Philipp Blanke, Georg Lutter, Derk Frank, Thomas Puehler, David A Wood, Lars Søndergaard, John G Webb.   

Abstract

BACKGROUND: THV implantation within failed surgical valves is well established. However the implications of THV implantation within failed THVs is poorly understood. AIMS: This study assessed the impact of different transcatheter heart valve (THV) designs and implant positioning strategies on hydrodynamic performance after redo transcatheter aortic valve implantation (TAVI).
METHODS: THVs of varying design (Sapien 3, Evolut Pro, Acurate neo, Allegra, and Portico) and sizes were implanted inside Sapien XT and Evolut R THVs. Hydrodynamic function as per International Standard Organization (ISO) specifications was evaluated using a pulse duplicator and multimodality imaging was performed.
RESULTS: The majority of tested THV-in-THV combinations resulted in stable anchoring of the new implant. However some combinations resulted in unstable anchoring with the potential for dislodgement or embolization. Hydrodynamic function was favourable for all tested THV designs implanted in the intra-annular Sapien XT THV. Sapien 3 implantation within an Evolut THV with supra-annular leaflets must be appropriately sized to ensure adequate anchoring. Avoidance of an intra-annular deployment mitigated leaflet overhang of the Evolut leaflets and optimized hydrodynamic performance.
CONCLUSIONS: This study demonstrates that most THV designs and implantation strategies can result in favourable hydrodynamic performance following redo-TAVI. Whether the leaflets of a failed THV are intra- or supra-annular may have important implications for the positioning of a redo-THV implant. Certain THV designs or implantation positions may be more desirable when performing redo-TAVI.

Entities:  

Year:  2021        PMID: 33495142     DOI: 10.4244/EIJ-D-20-00697

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  1 in total

1.  Redo Transcatheter Aortic Valve Implantation with the ALLEGRA Transcatheter Heart Valve: Insights from Bench Testing.

Authors:  Mariama Akodad; Maximilian Kütting; Stephanie Sellers; Alina Kirsten; Philipp Marx; Isabel Kim; Anson Cheung; Jonathon Leipsic; Lars Søndergaard; Stefan Toggweiler; David A Wood; John G Webb; Janarthanan Sathananthan
Journal:  Cardiovasc Eng Technol       Date:  2022-05-03       Impact factor: 2.495

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.